RJ Kok
RJ Kok
Verified email at uu.nl - Homepage
Title
Cited by
Cited by
Year
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
K Temming, RM Schiffelers, G Molema, RJ Kok
Drug resistance updates 8 (6), 381-402, 2005
5332005
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers, GA Koning, TLM ten Hagen, MHAM Fens, AJ Schraa, ...
Journal of Controlled Release 91 (1-2), 115-122, 2003
3822003
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status
R van der Meel, LJC Vehmeijer, RJ Kok, G Storm, EVB van Gaal
Advanced drug delivery reviews 65 (10), 1284-1298, 2013
3602013
Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy
M Everts, V Saini, JL Leddon, RJ Kok, M Stoff-Khalili, MA Preuss, ...
Nano letters 6 (4), 587-591, 2006
2912006
Preparation and Functional Evaluation of RGD-Modified Proteins as αvβ3 Integrin Directed Therapeutics
RJ Kok, AJ Schraa, EJ Bos, HE Moorlag, SA Ásgeirsdóttir, M Everts, ...
Bioconjugate chemistry 13 (1), 128-135, 2002
1992002
Diverse origins of the myofibroblast—implications for kidney fibrosis
LL Falke, S Gholizadeh, R Goldschmeding, RJ Kok, TQ Nguyen
Nature Reviews Nephrology 11 (4), 233, 2015
1842015
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritis
GA Koning, RM Schiffelers, MHM Wauben, RJ Kok, E Mastrobattista, ...
Arthritis & Rheumatism 54 (4), 1198-1208, 2006
1832006
Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α-and IL-1β-induced proinflammatory status of endothelial cells in vitro
JM Kułdo, J Westra, SA Ásgeirsdóttir, RJ Kok, K Oosterhuis, MG Rots, ...
American Journal of Physiology-Cell Physiology 289 (5), C1229-C1239, 2005
1802005
Targeting tumors with nanobodies for cancer imaging and therapy
S Oliveira, R Heukers, J Sornkom, RJ Kok, PMPB en Henegouwen
Journal of Controlled Release 172 (3), 607-617, 2013
1732013
Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme
RJ Kok, F Grijpstra, RB Walthuis, F Moolenaar, D De Zeeuw, DKF Meijer
Journal of Pharmacology and Experimental Therapeutics 288 (1), 281-285, 1999
1691999
A Novel Strategy to Modify Adenovirus Tropism and Enhance Transgene Delivery to Activated Vascular Endothelial Cells In Vitro and In Vivo
K Ogawara, MG Rots, RJ Kok, HE Moorlag, AM Van Loenen, DKF Meijer, ...
Human gene therapy 15 (5), 433-443, 2004
1652004
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges
F Ramazani, W Chen, CF van Nostrum, G Storm, F Kiessling, T Lammers, ...
International journal of pharmaceutics 499 (1-2), 358-367, 2016
1602016
Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats
M Moreno, T Gonzalo, RJ Kok, P Sancho‐Bru, M Van Beuge, J Swart, ...
Hepatology 51 (3), 942-952, 2010
1422010
Peptide-targeted PEG-liposomes in anti-angiogenic therapy
A Janssen, RM Schiffelers, TLM Ten Hagen, GA Koning, AJ Schraa, ...
International journal of pharmaceutics 254 (1), 55-58, 2003
1342003
Gold nanoparticles in theranostic oncology: current state-of-the-art
S Akhter, MZ Ahmad, FJ Ahmad, G Storm, RJ Kok
Expert opinion on drug delivery 9 (10), 1225-1243, 2012
1282012
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells
MEM Dolman, S Harmsen, G Storm, WE Hennink, RJ Kok
Advanced drug delivery reviews 62 (14), 1344-1357, 2010
1242010
Nanomedicines as cancer therapeutics: current status
S Akhter, I Ahmad, MZ Ahmad, F Ramazani, A Singh, Z Rahman, ...
Current cancer drug targets 13 (4), 362-378, 2013
1142013
Design, Synthesis, and Biological Evaluation of a Dual Tumor-specific Motive Containing Integrin-targeted Plasmin-cleavable Doxorubicin Prodrug 1 This work was partly supported …
FMH De Groot, HJ Broxterman, HPHM Adams, A Van Vliet, GI Tesser, ...
Molecular cancer therapeutics 1 (11), 901-911, 2002
1122002
How to screen non-viral gene delivery systems in vitro?
EVB van Gaal, R van Eijk, RS Oosting, RJ Kok, WE Hennink, ...
Journal of controlled release 154 (3), 218-232, 2011
1112011
Oxidative stress in obstructive nephropathy
A Dendooven, DA Ishola Jr, TQ Nguyen, DM Van der Giezen, RJ Kok, ...
International journal of experimental pathology 92 (3), 202-210, 2011
1102011
The system can't perform the operation now. Try again later.
Articles 1–20